These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24164599)
1. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375). Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599 [TBL] [Abstract][Full Text] [Related]
2. Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges. Kurata H; Gentry PR; Kokubo M; Cho HP; Bridges TM; Niswender CM; Byers FW; Wood MR; Daniels JS; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2015 Feb; 25(3):690-4. PubMed ID: 25542588 [TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators. Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343 [TBL] [Abstract][Full Text] [Related]
4. Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380). Gentry PR; Kokubo M; Bridges TM; Noetzel MJ; Cho HP; Lamsal A; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR J Med Chem; 2014 Sep; 57(18):7804-10. PubMed ID: 25147929 [TBL] [Abstract][Full Text] [Related]
5. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe. Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176 [TBL] [Abstract][Full Text] [Related]
6. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins. Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238 [TBL] [Abstract][Full Text] [Related]
7. Acute Negative Allosteric Modulation of M Gould RW; Gunter BW; Bubser M; Matthews RT; Teal LB; Ragland MG; Bridges TM; Garrison AT; Winder DG; Lindsley CW; Jones CK ACS Chem Neurosci; 2019 Aug; 10(8):3740-3750. PubMed ID: 31268669 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Allosteric Site at the M Burger WAC; Gentry PR; Berizzi AE; Vuckovic Z; van der Westhuizen ET; Thompson G; Yeasmin M; Lindsley CW; Sexton PM; Langmead CJ; Tobin AB; Christopoulos A; Valant C; Thal DM ACS Chem Neurosci; 2021 Aug; 12(16):3112-3123. PubMed ID: 34351123 [TBL] [Abstract][Full Text] [Related]
9. Continued optimization of the M McGowan KM; Nance KD; Cho HP; Bridges TM; Conn PJ; Jones CK; Lindsley CW Bioorg Med Chem Lett; 2017 Mar; 27(6):1356-1359. PubMed ID: 28237763 [TBL] [Abstract][Full Text] [Related]
10. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM. Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of M Gunter BW; Gould RW; Bubser M; McGowan KM; Lindsley CW; Jones CK Addict Biol; 2018 Sep; 23(5):1106-1116. PubMed ID: 29044937 [TBL] [Abstract][Full Text] [Related]